A circular RNA molecule helps dengue infection
The molecule circEPSTI1 enhances dengue virus replication by regulating a specific signaling axis.
The induction of circEPSTI1 was observed in plasma and peripheral blood mononuclear cells of dengue patients. This induction is interferon-dependent. It enhances dengue virus (DENV) infection.
Circular RNAs (circRNAs) are crucial regulators of gene expression. circEPSTI1 enhances infection by sponging the expression of miR-942-5p. This process involves the miR-942-5p-SERPINE1-AKT1 signaling axis.
The antiviral role of miR-942-5p is mediated through bidirectional inhibition. It targets the host AKT1 signaling pathway and conserved genomic sequences of the DENV genome. These sequences include NS1, NS3, and NS5.
RNA-seq analysis of DENV-infected circEPSTI1 knockdown A549 cells identified dysregulated SERPINE1 and AKT1 signaling pathways. circEPSTI1 relieves the inhibition of miR-942-5p over the host SERPINE1 and DENV genomic RNA. This activates AKT1 signaling.
The activation of AKT1 signaling facilitates cell survival and enhances DENV replication. SERPINE1 and circEPSTI1 were upregulated in dengue patients. Pharmaceutical inhibition of SERPINE1 through Tiplaxtinin inhibits DENV replication by reducing circEPSTI1 expression.
The results demonstrate the therapeutic potential of Tiplaxtinin. It targets the circEPSTI1-miR-942-5p-SERPINE1-AKT1 axis in dengue treatment.
Key facts
- circEPSTI1 induction is interferon-dependent in dengue patients.
- circEPSTI1 enhances DENV infection by sponging miR-942-5p.
- AKT1 signaling activation facilitates cell survival and DENV replication.
- Tiplaxtinin inhibits DENV replication by reducing circEPSTI1 expression.